Objective: The aim was to identify the prevalence of inadequate health literacy in patients with arterial vascular disease. This was a cross sectional study.
Targeting Phosphodiesterase-5 by Vardenafil Improves Vascular Graft Function
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Objectives: Ischaemia reperfusion (IR) injury occurs during vascular graft harvesting and implantation during vascular/cardiac surgery. Elevated intracellular cyclic guanosine monophosphate (cGMP) levels contribute to an effective endothelial protection in different pathophysiological conditions. The hypothesis that the phosphodiesterase-5 inhibitor vardenafil would protect vascular grafts against IR injury by upregulating the nitric oxideecGMP pathway in the vessel wall of the bypass graft was investigated.
Methods: Lewis rats (n = 6e7/group) were divided into Group 1, control; Group 2, donor rats received intravenous saline; Group 3, received intravenous vardenafil (30 mg/kg) 2 h before explantation. Whereas aortic arches of Group 1 were immediately mounted in an organ bath, aortic segments of Groups 2 and 3 were stored for 2 h in saline and transplanted into the abdominal aorta of the recipient. Two hours after transplantation, the implanted grafts were harvested. Endothelium dependent and independent vasorelaxations were investigated. TUNEL, CD-31, ICAM-1, VCAM-1, a-SMA, nitrotyrosine, dihydroethidium and cGMP immunochemistry were also performed.
Results: Compared with the control, the saline group showed significantly attenuated endothelium dependent maximal relaxation (R max ) 2 h after reperfusion, which was significantly improved by vardenafil supplementation (R max control, 91 6 2%; saline 22 6 2% vs. vardenafil 39 6 4%, p < .001). Vardenafil pre-treatment significantly reduced DNA fragmentation (control 9 6 1%, saline 66 6 8% vs. vardenafil 13 6 1%, p < .001), nitro-oxidative stress (control 0.8 6 0.3, saline 7.6 6 1.3 vs. vardenafil 3.8 6 1, p = .036), reactive oxygen species level (vardenafil 36 6 4, control 34 6 2 vs. saline 43 6 2, p = .049), prevented vascular smooth muscle cell damage (control 8.5 6 0.7, saline 4.3 6 0.6 vs. vardenafil 6.7 6 0.6, p = .013), decreased ICAM-1 (control 4.1 6 0.5, saline 7.0 6 0.9 vs. vardenafil 4.4 6 0.6, p = .031), and VCAM-1 score (control 4.4 6 0.4, saline 7.3 6 1.0 vs. vardenafil 5.2 6 0.4, p = .046) and increased cGMP score in the aortic wall (control 11.2 6 0.8, saline 6.5 6 0.8 vs. vardenafil 8.9 6 0.6, p = .016). The marker for endothelial integrity (CD-31) was also higher in the vardenafil group (control 74 6 4%, saline 22 6 2% vs. vardenafil 40 6 3%, p = .008).
Conclusions: The results support the view that impairment of intracellular cGMP signalling plays a role in the pathogenesis of the endothelial dysfunction of an arterial graft after bypass surgery, which can effectively be prevented by vardenafil. Its clinical use as preconditioning drug could be a novel approach in vascular/cardiac surgery.
Myocardial Injury is More Common than Deep Venous Thrombosis after Vascular Surgery and is Associated with a High One Year Mortality Risk
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Objective/background: Venous thromboembolism (VTE) has been considered the dominant major life threatening vascular complication after non-cardiac surgery, but recent studies have shifted the emphasis toward myocardial injury after non-cardiac surgery (MINS) as a common adverse event in the peri-operative setting. The aim of the present study was to compare the incidence and influence on mortality of two dominant venous and arterial events in the peri-operative period by prospectively screening a consecutive cohort of patients undergoing vascular surgery.
Methods: This was a sub-study of Vascular Events In Non-cardiac Surgery Patients Cohort Evaluation (VISION), the main objective of which was to evaluate major peri-operative complications after non-cardiac surgery. Patients undergoing vascular surgery had their blood collected to measure the Roche fifth generation high sensitivity troponin T (hsTnT) assay before and four times after surgery (6e12 h post-operatively, on the first, second, and third day following the procedure). MINS was defined as an elevated post-operative hsTnT $65 ng/L or an hsTnT $20 to <65 ng/L with an absolute change of $5 ng/L that was judged to be due to ischaemia. All patients underwent ultrasound venous compression testing for deep vein thrombosis (DVT) before, 4, and 7 days after surgery and follow-up was performed by telephone 30 days and 1 year after surgery.
Results: In total, 164 consecutive patients were included in this substudy. MINS was diagnosed in 39 patients (23.8%) and DVT in four patients (2.4%). The 1 year mortality was higher in MINS (9/39 [23.1%]) than non-MINS patients (9/125 [7.2%]; p = .006). None of the patients who developed DVT died in the first year after surgery.
Conclusion: MINS is a common complication after vascular surgery. It occurs more frequently than DVT and is associated with high 1 year mortality.
